Searched for
HAFFKINE RESEARCH INSTITUTE
Pharma Inc sets sights on monkeypox vaxPune-based Serum Institute of India , Reliance Life Sciences, Dr Reddy's Laboratories, Biological E and two state-owned units - Mumbai-base...- Moringa, superfood filled with nutrients, can help tackle urban malnutrition problemsAs urbanisation increases in India, fuelled by climate change, such problems of nutritional deficiency, like the child stunting that NFHS-5...
- Suresh Jadhav, key executive of SII & doyen of vaccine industry, passed awayJadhav has been with SII for over four decades, playing a crucial role in building SII as the world's largest vaccine producer. As part of ...
- Monthly production capacity of Covishield, Covaxin planned to be increased: GovtFrom January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by B...
- Monthly production capacity of Covishield projected to increase to 120 million doses, Covaxin to 58 million doses: MinisterUnion Health Minister Mansukh Mandaviya was responding to a question on the current capacity to manufacture Covaxin and Covishield in the c...
- Bharat Biotech’s Covaxin supply falls short of government ordersAccording to the Centre's affidavit, over 1.8 million doses of Covaxin are pending against its order for 20 million doses in March.
- Covaxin output may hit 100 million doses per month by November“For Covaxin, we will see a significant (production) ramp-up of more than double in August-September, when the doses manufactured by Bharat...
- What pharma PSUs and government vaccine makers can and cannot do in the uphill battle against CovidWhile government-owned pharma companies are ailing from years of neglect, some have rolled up their sleeves and joined India’s uphill battl...
- Government exploring possibility of Covaxin production outside IndiaThe government also intends to take up the matter with the World Health Organisation (WHO) to step up Covaxin production.
- Gujarat govt in talks with Bharat Biotech to ramp up production of Covaxin: DBT"Further, Gujarat Biotechnology Research Centre, Department of Science and Technology Govt of Gujarat along with Hester Biosciences and Omn...
- Apply the law to accelerate Covaxin output: India has enough legal provisions to make it happen, say expertsBharat Biotech had issued a statement saying, “Capacity expansion has been implemented across multiple facilities... to reach 700 million d...
- India's vaccinations fall from peak, raw-material shortage hits output targetsAfter giving and selling tens of millions of COVID-19 vaccine doses abroad, India has suddenly found itself short of shots. It has abruptly...
- PM meet: Maharashtra CM seeks more vaccination centres, Haffkine nodMaharashtra Chief Minister Uddhav Thackeray on Wednesday sought approval for starting more vaccination centres to expedite inoculation in t...
- Maharashtra plans clinical trials of TB vaccine BCG to treat Covid-19The 121-year-old institute’s trial is intended for patients who are moderately ill with Covid-19 and is likely to be carried out in small b...
- Private labs earn crores from H1N1 hysteria in MumbaiPrivate laboratories in the city made staggering profits as around 15,000 panicstricken citizens spent over Rs 8.25 crore on H1N1 tests.
- Homoeopathy research showcase at World Summit may spell new hope for HIV, tuberculosis patientsIn a pioneering two-year long study, city-based homoeopath Dr Rajesh Shah has developed a new medicine for AIDS patients, sourced from huma...
- Government leaves vaccine space for private companiesThe government has decided not to revive the four state-owned vaccine units whose licences were recently suspended.
- Govt suspends manufacturing licence of 4 drug firmsUnion health ministry has suspended the manufacturing licence of four leading state-owned drug makers for violating the good manufacturing ...
Load More
